All News



Celgene Becomes TechAdvance's First Corporate Donor

Published: July 26, 2018

The TechAdvance Fund has received its first corporate donation in support of its gap funding mission. Celgene Corporation made a generous contribution to the fund, becoming the first corporate partner since the program began in June 2017

Celgene’s donation to the Rutgers TechAdvance fund is consistent with the company's entrepreneurial vision to enable bold pursuits in science and to support the start-up ecosystem in NJ and around the world. This mission is further demonstrated by the establishment of the Thomas O. Daniel Research Incubator and Collaboration Center on the Celgene campus.

— Rupert Vessey, FRCP, DPhil, President of Research and Early Development, Celgene Corporation

Thus far, TechAdvance has awarded $1.45 million to 22 researchers.

The TechAdvance program serves as a catalyst to move Rutgers inventions beyond that basic research stage and into the marketplace for practical application. Celgene’s donation enhances our efforts to encourage invention and entrepreneurship among Rutgers researchers as they develop new solutions to real-world problems. We are grateful for Celgene’s support and shared commitment to advancing innovation at Rutgers and improving lives.

— Christopher J. Molloy, PhD, RPh, Senior Vice President for Research and Economic Development at Rutgers

Established with seed funding from the Office of Research and Economic Development (ORED), TechAdvance continues to be supported by the university and alumni, foundations and buisness community donations.

To view the full press release, visit the ORED News page.